These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3264220)

  • 1. [Comparative study of the rat paw edema test for evaluating the reactivity of combined vaccines containing a pertussis component].
    Průchová J; Karel J; Vrána M; Elis J; Blazek Z
    Cesk Farm; 1988 Sep; 37(7):322-6. PubMed ID: 3264220
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of rat-paw oedema tests for assessing reactivity of B. pertussis-containing combined vaccines.
    Průchova J; Karel J; Vrána M; Elis J; Blazek Z
    Dev Biol Stand; 1986; 65():177-83. PubMed ID: 2881822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the toxicity of the pertussis component of the Di-Te-Per vaccine].
    Gołobów M; Kardymowicz B; Kudelski Z; Rymkiewicz D; Sawicki J
    Med Dosw Mikrobiol; 1986; 38(1):9-14. PubMed ID: 2423821
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and immunogenicity of a diphtheria-tetanus-pertussis vaccine containing an acellular pertussis component.
    Badgett JT; Rodgers GC
    South Med J; 1987 Sep; 80(9):1075-8. PubMed ID: 3498218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse toxicity of triple vaccine (DTP) mixed with poliomyelitis vaccine.
    Gottshall RY; Anderson GR; Nelson EA; Wilcox KR
    Mich Med; 1969 Feb; 68(3):131-4. PubMed ID: 5763453
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the epinephrine-refractory hypoglycaemic activity of whole-cell pertussis vaccine in mice.
    Horiuchi Y; Iida T
    J Biol Stand; 1988 Oct; 16(4):239-48. PubMed ID: 3143732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swelling of the brain in mice caused by pertussis vaccine--its quantitative determination and the responsible factors in the vaccine.
    Iwasa S; Ishida S; Akama K
    Jpn J Med Sci Biol; 1985 Apr; 38(2):53-65. PubMed ID: 3878421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assays of pertussis vaccine toxicity in mice and chicks.
    Guérault A; Quevillon M
    Prog Immunobiol Stand; 1967; 3():327-31. PubMed ID: 5379954
    [No Abstract]   [Full Text] [Related]  

  • 11. Acellular pertussis vaccines: evaluation of reversion in a nude mouse model.
    Quentin-Millet MJ; Arminjon F; Danve B; Cadoz M; Armand J
    J Biol Stand; 1988 Apr; 16(2):99-108. PubMed ID: 3259580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine.
    Speijers GJ; Danse LH; Beuvery EC; Strik JJ; Vos JG
    Fundam Appl Toxicol; 1988 Apr; 10(3):425-30. PubMed ID: 3259520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbance of cardiovascular circadian rhythms by pertussis vaccine in freely-moving rats.
    Vleeming W; van de Kuil A; te Biesebeek JD; van der Laan JW; de Wildt DJ; van Amsterdam JG
    Lab Anim; 2000 Oct; 34(4):399-402. PubMed ID: 11072860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and toxicity testing of pertussis vaccine.
    Kurokawa M
    Jpn J Med Sci Biol; 1984 Apr; 37(2):41-81. PubMed ID: 6207324
    [No Abstract]   [Full Text] [Related]  

  • 15. The pyrogenicity of pertussis vaccine in mice and the factors in the vaccine responsible for this effect.
    Ishida S; Iwasa S; Fujiwara H; Chazono M; Akama K
    J Biol Stand; 1989 Jan; 17(1):41-51. PubMed ID: 2784132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the toxicity of pertussis vaccines by means of laboratory tests].
    Fedoseeva TM
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):20-6. PubMed ID: 5615859
    [No Abstract]   [Full Text] [Related]  

  • 17. The laboratory evaluation os polyvalent vaccine against diphtheria, tetanus and whooping cough using the rat pad oedema test. I. The evaluation of local reactivity after administration of a combined vaccine.
    Demelová M; Francová D; Malý V
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):368-78. PubMed ID: 5629952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drying of adsorbed pertussis-diphtheria-tetanus vaccine].
    Tseligorova NS; Usikov FD
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):71-4. PubMed ID: 5787575
    [No Abstract]   [Full Text] [Related]  

  • 19. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of tolerance to diphtheria-pertussis-tetanus vaccines].
    Künzel W; Meissner C; Lüderitz U; Willkommen H; Winkler C
    Padiatr Grenzgeb; 1986; 25(2-3):197-203. PubMed ID: 3523392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.